Genzyme and Isis Provide Update on CHMP Opinion on KYNAMROâ„¢ (mipomersen)

Genzyme and Isis Provide Update on CHMP Opinion on KYNAMROâ„¢ (mipomersen)

[at noodls] – )–Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), and Isis Pharmaceuticals Inc. (NASDAQ: ISIS), today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European … more

View todays social media effects on SAN

View the latest stocks trending across Twitter. Click to view dashboard

See who Banco is hiring next, click here to view

Share this post